Ketoprofen in the treatment of rheumatoid arthritis. Double-blind, cross-over placebo comparison.
In a two week double-blind cross-over trial of ketoprofen versus placebo in twelve patients, ketoprofen was shown to have substantial anti-inflammatory activity and to be more effective than placebo. Clinical and biological tolerance were excellent.